Cargando…
Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options
Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic liver disease which is associated with Inflammatory Bowel Disease (IBD) in 70% of cases. It seems PSC/IBD is a distinct phenotype that is different from PSC, and IBD alone. Hence, we review the epidemiology, pathogenesis, natural course a...
Autores principales: | Hatami, Behzad, Pasharavesh, Leila, Sharifian, Afsaneh, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520392/ https://www.ncbi.nlm.nih.gov/pubmed/37767322 http://dx.doi.org/10.22037/ghfbb.v16i2.2589 |
Ejemplares similares
-
Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
por: Hatami, Behzad, et al.
Publicado: (2022) -
Liver transplantation for post-COVID-19 sclerosing cholangitis
por: Lee, Angela, et al.
Publicado: (2021) -
An update on treatment options for primary sclerosing cholangitis
por: Iravani, Shahrokh, et al.
Publicado: (2020) -
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management
por: Kumar, Aditi, et al.
Publicado: (2016) -
An overview of recent treatment options for primary sclerosing cholangitis
por: Mousavere, Ioanna, et al.
Publicado: (2023)